Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  BARIATRIC (OBESITY) SURGICAL DEVICES
A US & European Market Report

This report analyzes the US and European markets for Bariatric (Obesity) Surgical Devices in Millions of US$. The US market for Bariatric Surgical Devices is analyzed by the following segments: Gastric Bypass Devices, and Gastric Banding Devices. The European market is separately analyzed by the following segments: Adjustable Gastric Banding Devices, Gastric Bypass Devices, and Intragastric Balloon Devices. Annual forecasts are provided for the period of 2005 through 2015. The report profiles 49 companies including many key and niche players worldwide such as Allergan, Inc., Cousin Biotech, Covidien Ltd., Ethicon Endo-Surgery, Inc., Helioscopie SA, Medical Innovation Development Company, PARÉ Surgical, Inc., Satiety, Inc., Silimed Ltda., and Surgical IOC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-5042  PAGES:    284
PRICE:    $2450  DATE:       July 2009
COMPANIES:  49  MARKET DATA TABLES:   96
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  BARIATRIC (OBESITY) SURGICAL DEVICES (Complete Report) Pages : 284   | $2450
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2  
   Data Interpretation & Reporting Level.....I-3
Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Obesity Assumes Epidemic Proportions.....II-1
Growing Problem of Obesity in Asia Particularly China.....II-1
1$100
   Obesity – Quick Statistics.....II-2 1$100
   Table 1: Global Overweight Prevalence (2006): Overweight Population (%) of Select Countries (BMI > 25) (includes corresponding Graph/Chart).....II-3

Table 2: Obese and Overweight & Obese Population in the World (2009): Percentage Share Breakdown by Region for US, European Union, and Rest of World (includes corresponding Graph/Chart).....II-3
1$300
   Table 3: Abdominal Obesity Prevalence (%) by Region and Sex (includes corresponding Graph/Chart).....II-4
Surgery Provides Hope for Morbidly Obese Patients.....II-4
1$300
   Growing Obesity Prevalence Drives Development of Weight Loss Therapies.....II-5
1$100
   Relevance of Bariatric Surgery in Pediatrics.....II-6
Sleeve Gastrectomy – Challenging the Growth of Banding Procedures.....II-6
1$100
   Compliance Trends with Physician Advise in Post-Surgery Scenario.....II-7
Recommendation Compliance After Surgery - Weight Loss in Compliant and Non-Compliant
  Patients.....II-7
Risk of Bariatric Surgery on Pregnancy.....II-7
1$100
   Stomaphyx Surgery – Addressing Post-Surgical Complications.....II-8
VBLOC – An Alternative to Bariatric Surgery.....II-8
Endobarrier – An Experimental Device Offers Alternative to Surgery.....II-8
Competition Intensifies in the Bariatric Surgery Market.....II-8
2$200
   Obesity – A Conceptual Definition.....II-10
Childhood Obesity.....II-10
Causes of Obesity.....II-10
1$100
   Dietary Habits.....II-11
Sedentary Lifestyle.....II-11
Genetic Factors.....II-11
Medical and Psychiatric Illnesses.....II-11
1$100
   Socioeconomic Factors.....II-12
Diagnosis of Obesity.....II-12
Body Mass Index (BMI).....II-12
Classification of Obesity as per BMI.....II-12
1$100
   Classification for Class III Obesity.....II-13
Deriving Body Fat Percentage from BMI.....II-13
Central Obesity.....II-13
1$100
   Central Obesity in Men and Women – Criteria for Identification Using Absolute Waist
  Circumference and Waist-Hip Ratio Methods.....II-14
Impact of Obesity on Health.....II-14
Mortality.....II-14
Morbidity.....II-14
Major Obesity-Related Diseases.....II-14
1$100
   Obesity Treatment.....II-151$100
   Diet Therapy.....II-16
Lifestyle Modification.....II-16
Pharmacotherapy.....II-16
Medical Devices.....II-16
Bariatric Surgery.....II-16
Clinical Protocols for Obesity Treatment.....II-16
1$100
   Defining Bariatrics.....II-17
Bariatric Surgery.....II-17
Patient Eligibility for Bariatric Surgery.....II-17
1$100
   Role of Technologies in the Growth of Bariatric Surgery.....II-18
Endoluminal and Transgastric Surgeries.....II-18
Laparoscopy.....II-18
1$100
   Endoscopy in Bariatric Surgery.....II-19
Advantages of Bariatric Surgery.....II-19
Disadvantages of Bariatric Surgery.....II-19
2$200
   Surgical Treatment for Obesity.....II-21
Classification of Bariatric Surgery Procedures.....II-21
Restrictive Procedures.....II-21
1$100
   Vertical Banded Gastroplasty.....II-22
Laparoscopic Adjustable Gastric Banding.....II-22
World Estimates and Forecasts.....II-22
1$100
   Table 4: World Recent Past, Current & Future Analysis for Bariatric Surgery: Annual Number of Gastric Banding Procedures for Years 2005 through 2015 (in Thousands) (includes corresponding Graph/Chart).....II-23
Eligibility Criteria for Gastric Banding Patients.....II-23
Advantages of Gastric Banding.....II-23
1$300
   Adverse Effects of Banding.....II-24
Malabsorptive Procedures.....II-24
1$100
   Biliopancreatic Diversion Procedure.....II-25
Biliopancreatic Diversion with Duodenal Switch.....II-25
1$100
   Benefits & Drawbacks of the Procedure.....II-26
Combination Procedures.....II-26
Gastric Bypass Surgery.....II-26
1$100
   Table 5: Effectiveness of Gastric Bypass Surgery (includes corresponding Graph/Chart).....II-27
Surgical Techniques for Gastric Bypass.....II-27
Variations of Gastric Bypass.....II-27
Loop Gastric Bypass.....II-27
1$300
   Mini Gastric Bypass.....II-28
Table 6: Key Performance Characteristics of Laparoscopic Mini Gastric Bypass Surgery.....II-28
Long-Limb Gastric Bypass.....II-28
Gastric Bypass, Roux En-Y (Proximal).....II-28
1$300
   Gastric Bypass, Roux en-Y (Distal).....II-29
Open Vs Laparoscopic Gastric Bypass Surgery.....II-29
Complications of Gastric Bypass Procedure.....II-29
Anastamotic Leakage.....II-29
Anastamotic Stricture.....II-29
Dumping Syndrome.....II-29
1$100
   Major Complications of Laparoscopic Gastric Bypass.....II-30
Sleeve Gastrectomy.....II-30
1$100
   Analysis of Various Bariatric Procedures.....II-31
Table 7: A Comparative Analysis of Various Bariatric Surgery Procedures.....II-31
1$300
   Table 8: Efficacy Rates of Bariatric Procedures (At 2 Year of Surgery).....II-32
Gastric Banding Vs Gastric Bypass.....II-32
1$300
   Table 9: Comparison of Gastric Band & Gastric Bypass Surgeries.....II-33
1$300
   Adjustable Gastric Bands.....II-34
Background.....II-34
Available Gastric Bands.....II-34
1$100
   Adjustable Gastric Bands Marketed in the US and Europe.....II-35
Allergan & Ethicon Vie for Global Gastric Band Market Share.....II-35
1$100
   Table 10: Leading Players in the Global Gastric Bands Market (2007): Percentage Share Breakdown of Value Sales for Allergan, Johnson & Johnson/Ethicon, and Others (includes corresponding Graph/Chart).....II-36
Lap-Band Vs Realize Band.....II-36
Intragastric Balloons.....II-36
1$300
   Implantable Gastric Stimulator (IGS).....II-37
Surgical Clamps/Gastric Surgery Clamps.....II-37
Clip Applier.....II-37
1$100
   Endo Stitch.....II-38
Pneumoperitoneum Needle.....II-38
Surgical Staple.....II-38
Trocars.....II-38
1$100
   Bariatric Surgery Reduces Complications Associated with NAFLD.....II-39
Research Finds Lower Maternal Risks Among Surgery- Treated Obesity Patients.....II-39
1$100
   Metabolic Syndrome Affects In-Hospital Outcomes After Bariatric Surgery.....II-401$100
   Researchers Assess Pulmonary Aspiration Risk in Bariatric Surgery Patients.....II-41
Post-Operative Outcomes of Bariatric Surgeries.....II-41
Gastric Bypass Surgery Improves Immune Response of Patients.....II-41
Bariatric Surgery Reduces Cancer Risk.....II-41
1$100
   Study Shows Need for Re-Surgery in Banding Surgery Patients.....II-42
Gastric Banding Surgery Improves Resistance to Insulin.....II-42
1$100
   Covidien Introduces Versaport™ Plus Bladeless Trocar Line.....II-43
West Penn Bariatric Surgery Center Commences use of REALIZE Gastric Band.....II-43
Ethicon Receives FDA Approval to Market REALIZE™.....II-43
Swan Medical Devices Introduces Intraluminal Gastroplasty Device.....II-43
1$100
   Allergan Acquires EndoArt.....II-44
Allergan and Covidien to Co-promote Lap-Band.....II-44
Taiwan Approves Intragastric Balloon Treatment.....II-44
Cellular Technical Services Takes Over SafeStitch.....II-44
1$100
   USGI Medical to Use EOS.....II-45
Synovis Acquires 4Closure™ Surgical Fascia Closure System.....II-45
Allergan Acquires Inamed.....II-45
Medtronic Acquires Transneuronix.....II-45
1$100
   EnteroMedics and Mayo Enter into R&D Agreement.....II-46
1$100
   Allergan, Inc. (US).....II-47
Cousin Biotech (France).....II-47
Covidien Ltd. (Bermuda).....II-47
1$100
   Ethicon Endo-Surgery, Inc. (US).....II-48
Helioscopie SA (France).....II-48
Medical Innovation Development Company (France).....II-48
PARÉ Surgical, Inc. (US).....II-48
Satiety, Inc. (US).....II-48
1$100
   Silimed Ltda (Brazil).....II-49
Surgical IOC (France).....II-49
1$100
   A. Market Analysis.....III-1
Outlook.....III-1
Obesity – A Major Concern for Healthcare Industry.....III-1
Factors Contributing to Rising Incidence of Obesity.....III-1
1$75
   A Quick Glance at Obesity Statistics.....III-2 1$75
   Table 11: Obesity-Affected Population in the US (2009): Percentage Share Breakdown by Age Group (includes corresponding Graph/Chart).....III-3

Table 12: Proportion (%) of Obesity in the US Overweight Population by Age Group (includes corresponding Graph/Chart).....III-3
1$150
   Table 13: US Obesity Rate (2007): Prevalence Rate by Leading States.....III-41$150
   Bariatric Surgery – Ultimate Option for Obesity Treatment.....III-5
Bariatric Surgery – Fast Facts.....III-5
Focus on Physical Well-Being Boosts Bariatric Surgery Market.....III-5
1$75
   Growth Drivers.....III-6
Market Restraints.....III-6
Rapid Growth in Bariatric Surgery Devices Market.....III-6
1$75
   Surgery Market for Adolescent Obesity– Slow & Steady Growth.....III-7
Gastric Banding – A Market Set for Rapid Growth.....III-7
Laparoscopic Adjustable Gastric Banding Gains Popularity.....III-7
1$75
   LGB Vs LGBP – Cost Comparison.....III-8
Robot-Assisted Gastric Bypass Surgery Rises in Popularity.....III-8
Reimbursement Scenario.....III-8
1$75
   Insurance Coverage.....III-9
CMS Offers Coverage for Bariatric Surgery.....III-9
Lack of Sufficient Coverage – A Major Obstacle.....III-9
1$75
   Competition Intensifies in the US Gastric Banding Market.....III-10
Table 14: Leading Players in the US Adjustable Gastric Banding Market (2006 & 2008): Percentage Share Breakdown of Revenues for Allergan and Johnson & Johnson.....III-10
1$150
   Product Launches.....III-111$75
   Strategic Corporate Developments.....III-122$150
   Key Players.....III-14
Allergan, Inc......III-14
Ethicon Endo-Surgery, Inc......III-14
PARÉ Surgical, Inc......III-14
Satiety, Inc......III-14
1$75
   B. Market Analytics.....III-15
Table 15: US Recent Past, Current & Future Analysis for Bariatric Surgery: Annual Number of Gastric Bypass and Gastric Banding Procedures for Years 2005 through 2015 (in Thousands) (includes corresponding Graph/Chart).....III-15

Table 16: US 10-Year Perspective for Bariatric Surgical Procedures by Segment – Percentage Breakdown of Gastric Bypass and Gastric Banding Procedures for Years 2006, 2009 & 2015.....III-15
1$150
   Table 17: US Recent Past, Current & Future Analysis for Bariatric Surgical Devices by Segment - Gastric Bypass and Gastric Banding Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2005 through 2015 (includes corresponding Graph/Chart).....III-16

Table 18: US 10-Year Perspective for Bariatric Surgical Devices by Segment – Percentage Breakdown of Annual Revenues for Gastric Bypass and Gastric Banding Markets for Years 2006, 2009 & 2015.....III-16
1$150
   A. Market Analysis.....III-17
Outlook.....III-17
Obese Population in Europe.....III-17
Table 19: Obese and Overweight & Obese Population in the European Union (2009): Percentage Share Breakdown by Age Group.....III-17
1$150
   Table 20: Obesity Prevalence (2007) in Select European Union Countries: Obesity Rates by Gender (includes corresponding Graph/Chart).....III-18

Table 21: Europe Obesity Prevalence (2007) by Gender and Age Category (in 000s) (includes corresponding Graph/Chart).....III-18
1$150
   Bariatric Surgery in Europe.....III-19
Growing Awareness Levels to Boost Surgery Devices Market.....III-19
1$75
   Factors Driving the European Bariatric Surgery Devices Market.....III-20
Factors Restraining Growth in the European Bariatric Surgery Devices Market.....III-20
Pricing Scenario.....III-20
Gastric Bypass Surgery Gains Strength.....III-20
1$75
   Reimbursement Scenario in Europe.....III-211$75
   Reimbursement Policies in Select European Countries.....III-22
Competitive Landscape.....III-22
1$75
   Table 22: Leading Players in the European Bariatric Surgical Devices Market (2007): Percentage Share Breakdown of Revenues for Ethicon Endo Surgery, Allergan/Inamed, Covidien, and Others (includes corresponding Graph/Chart).....III-23
B. Market Analytics.....III-23
Table 23: European Recent Past, Current & Future Analysis for Bariatric Surgical Devices by Geographic Region – France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2005 through 2015 (includes corresponding Graph/Chart).....III-23
1$150
   Table 24: European 10-Year Perspective for Bariatric Surgical Devices by Geographic Region – Percentage Breakdown of Annual Revenues for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....III-241$150
   Table 25: European Recent Past, Current & Future Analysis for Bariatric Surgical Devices by Segment - Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2005 through 2015 (includes corresponding Graph/Chart).....III-251$150
   Table 26: European 10-Year Perspective for Bariatric Surgical Devices by Segment – Percentage Breakdown of Annual Revenues for Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....III-26
1$150
   A. Market Analysis.....III-27
Outlook.....III-27
Obesity – A Major Health Concern.....III-27
Key Players.....III-27
Cousin Biotech.....III-27
Helioscopie SA.....III-27
1$75
   Medical Innovation Development Company.....III-28
Surgical IOC.....III-28
1$75
   B. Market Analytics.....III-29
Table 27: French Recent Past, Current & Future Analysis for Bariatric Surgical Devices by Segment - Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets Independently Analyzed with Annual Revenuesin US$ Million for Years 2005 through 2015 (includes corresponding Graph/Chart).....III-29
1$150
   Table 28: French 10-Year Perspective for Bariatric Surgical Devices by Segment – Percentage Breakdown of Annual Revenues for Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....III-30
1$150
   A. Market Analysis.....III-31
Outlook.....III-31
Overview.....III-31
Bariatric Solutions GmbH – A Key Player.....III-31
1$75
   B. Market Analytics.....III-32
Table 29: German Recent Past, Current & Future Analysis for Bariatric Surgical Devices by Segment - Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2005 through 2015 (includes corresponding Graph/Chart).....III-32
1$150
   Table 30: German 10-Year Perspective for Bariatric Surgical Devices by Segment – Percentage Breakdown of Annual Revenues for Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....III-33
1$150
   Market Analysis.....III-34
Table 31: Italian Recent Past, Current & Future Analysis for Bariatric Surgical Devices by Segment - Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2005 through 2015 (includes corresponding Graph/Chart).....III-34
1$150
   Table 32: Italian 10-Year Perspective for Bariatric Surgical Devices by Segment – Percentage Breakdown of Annual Revenues for Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....III-35
1$150
   A. Market Analysis.....III-36
Outlook.....III-36
Overview.....III-36
1$75
   B. Market Analytics.....III-37
Table 33: UK Recent Past, Current & Future Analysis for Bariatric Surgical Devices by Segment - Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2005 through 2015 (includes corresponding Graph/Chart).....III-37
1$150
   Table 34: UK 10-Year Perspective for Bariatric Surgical Devices by Segment – Percentage Breakdown of Annual Revenues for Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....III-38
1$150
   Market Analysis.....III-39
Table 35: Spanish Recent Past, Current & Future Analysis for Bariatric Surgical Devices by Segment - Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2005 through 2015 (includes corresponding Graph/Chart).....III-39
1$150
   Table 36: Spanish 10-Year Perspective for Bariatric Surgical Devices by Segment – Percentage Breakdown of Annual Revenues for Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....III-40
1$150
   A. Market Analysis.....III-41
Overview.....III-41
Gastric Banding Market Gains Strength.....III-41
Belgium.....III-41
The Netherlands.....III-41
Juvenile Obesity – A Major Cause of Concern.....III-41
1$75
   Finland.....III-42
Sweden.....III-42
Strategic Corporate Developments.....III-42
New2DM S.A (Luxembourg) – A Major Player.....III-42
1$75
   B. Market Analytics.....III-43
Table 37: Rest of Europe Recent Past, Current & Future Analysis for Bariatric Surgical Devices by Segment - Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2005 through 2015 (includes corresponding Graph/Chart).....III-43
1$150
   Table 38: Rest of Europe 10-Year Perspective for Bariatric Surgical Devices by Segment – Percentage Breakdown of Annual Revenues for Adjustable Gastric Banding, Gastric Bypass Devices, and Intragastric Balloon Devices Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....III-441$150
  
Total Companies Profiled: 49 (including Divisions/Subsidiaries - 64)

Region/Country Players

The United States 35 Canada 2 Japan 2 Europe 25 France 4 Germany 12 The United Kingdom 2 Rest of Europe 7
Click here to request a full table of contents and more details on this project.
  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.